Tower Research Capital (TRC)’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Tower Research Capital (TRC)’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-826	Closed	-$51.4K	–	6297
2023 Q4	$51.4K	Buy	826 +662	+404%	+$16.5K	﹤0.01%	3117
2023 Q3	$3.64K	Buy	+164	New	+$3.44K	﹤0.01%	4979

Tower Research Capital (TRC)'s RYZB Position: Q1 2024 in Review

Tower Research Capital (TRC) sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 826 shares — an estimated $51.4K sold.

Tower Research Capital (TRC) first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $51.4K in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Tower Research Capital (TRC) reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Tower Research Capital (TRC) sold 826 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $51.4K.
Tower Research Capital (TRC) first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Tower Research Capital (TRC)'s RayzeBio, Inc. Common Stock position peaked at $51.4K in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.